Jarro-Dophilus Infant 1 Billion CFU By Jarrow Formulas Overview & Drug Interactions
Check For Interactions With Jarro-Dophilus Infant 1 Billion CFU
Supplement: Jarro-Dophilus Infant 1 Billion CFU by Jarrow Formulas
Jarro-Dophilus Infant 1 Billion CFU Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Bifidobacterium longum infantis M-63
| Ingredient Group | Bifidobacterium infantis |
|---|---|
| Category | bacteria |
Drugs that interact with Jarro-Dophilus Infant 1 Billion CFU by Jarrow Formulas
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with Jarro-Dophilus Infant 1 Billion CFU. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
0.5 mL
|
| Maximum serving Sizes: |
0.5 mL
|
| Servings per container | 30 |
| UPC/BARCODE | 790011030140 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Bifidobacterium longum infantis M-63 |
12.5 mg
|
Bifidobacterium infantis |
--
|
| Other Ingredients: |
Medium Chain Triglyceride
Forms
Tapioca Starch
Calcium Phosphate
D-Alpha-Tocopherol
Forms
Citric Acid
|
|---|
Label Statments:
| Formula |
- Bifidobacterium Longum Subsp. Infantis M-63
Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune system.
B. infantis is the predominant intestinal organism found in breast-fed infants. B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants.
B. infantis is the only bacterial species to utilize Human Milk Oligosaccharides (HMOs) components made by fermentation (such as 2'-FL and 3'-SL), which allows B. infantis to outcompete other species.
Jarro-Dophilus Infant is formulated with medium chain triglycerides (MCT), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.
- Clinically studied B. infantis M-36
Liquid probiotic
|
|---|---|
| General Statements |
- The developing intestinal microflora of a newborn is up to 90% B. infantis.
- Probiotics
|
| Storage |
- Live Probiotic Guarantee
When kept under recommended storage conditions, Jarrow Probiotics are formulated to ensure CFU counts are guaranteed within Best Used Before date.
Store in a cool, dry place.
- Once the bottle has been opened, use within 30 days.
- No refrigeration necessary
Does not require refrigeration and can be stored at room temperature in a cool, dry place. Avoid storage at temperature above 77 degrees F (25 degrees C). Refrigeration, however extends shelf life.
|
| FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
| Suggested/Recommended/Usage/Directions |
- Suggested Use: For newborns to infants up to 6 months old, add once half dropper (0.5 mL), once a day, to foods, lukewarm milk, or infant formula. Or use as directed by your qualified healthcare professional. Shake bottle well before each use. Once bottle has been opened, use within 30 days.
|
| Formulation |
- Strains Matter
When it comes to effective probiotics, clinically documented Strains Matter. As an innovator of consumer probiotics since 1986, Jarrow Formulas takes great pride in using high-quality and scientifically documented strains that have been developed through years of research and innovation.
- Vegan
- Promotes infant intestinal health
- Non-GMO
Gluten free
- No wheat, gluten, soybeans, dairy, egg, fish/shellfish, peanuts/tree nuts or sesame.
|
| Precautions |
- Warning: Consult a healthcare professional before using this product if your child has a medical condition; if adverse reactions occur, discontinue use. Keep out of the reach of children.
- Do not use if safety seal is damaged or missing.
|
| Seals/Symbols |
- IPRO
|
| FDA Statement of Identity |
- Probiotics Supplement
|
| Brand IP Statement(s) |
- Copyright 2023 Jarrow Formulas
U.S. Patent No: 11,019,838 B2
|
Brand Information
See all products by this brand
| Distributed by | |
|---|---|
| Name | Jarrow Formulas, Inc. |
| City | Sherman Oaks |
| State | CA |
| Country | USA |
| ZipCode | 91403 |
| Phone Number | 1-866-459-4154 |
| Web Address | www.Jarrow.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.